NASDAQ:NSPH (NSPH) (NSPH) Stock Price, News & Analysis → “The Stock Market’s Bull Run is Far from Over” -Barrons (From Vertical Research Advisory) (Ad) Free NSPH Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$1.69▼$1.6950-Day Range N/A52-Week Range$0.48▼$3.64VolumeN/AAverage Volume886,293 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (NSPH) alerts: Email Address Ad Vertical Research Advisory“The Stock Market’s Bull Run is Far from Over” -BarronsBarron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!Click here for all the details now… About (NSPH) Stock (NASDAQ:NSPH)Nanosphere, Inc. is engaged in developing, manufacturing and marketing an advanced molecular diagnostics platform, the Verigene System, which enables genomic and protein testing on a single platform. The Verigene System includes a molecular diagnostics workstation that is a single use consumable for testing. The Verigene System consists of a microfluidics processor, a touchscreen reader and disposable test cartridges. The Company is focused on the infectious disease diagnostics market. Its Infectious Disease Assays include Respiratory Virus with Sub-Typing (RV+); Respiratory Pathogens/Expanded Panel (RP Flex); Bloodstream Infection (BSI) Panels, which include Blood Culture – Gram Positive (BC-GP), Blood Culture – Gram Negative (BC-GN) and Blood Culture – Yeast (BC-Y); C. difficile (CDF), and Enteric Panel (EP). Its Human Pharmacogenetic Assays include Hypercoagulation (FV, FII, MTHFR Panel) and CYP2C19 Genetic Variance. It is focused on the infectious disease diagnostics market.Read More Ad Vertical Research Advisory“The Stock Market’s Bull Run is Far from Over” -BarronsBarron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!Click here for all the details now… NSPH Stock News HeadlinesApril 13, 2023 | msn.comLIVE FEED: Police, Correctional Services give update on Thabo Bester, Dr Nandipha Magudumana’s arrestsMarch 8, 2023 | msn.comMichelle Yeoh deletes post some saw as a slam on fellow Oscar nominee Cate BlanchettMarch 28, 2024 | Vertical Research Advisory (Ad)“The Stock Market’s Bull Run is Far from Over” -BarronsBarron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!December 29, 2022 | msn.comTitans' Teair Tart takes a spill trying to celebrate fumble vs. CowboysDecember 17, 2022 | msn.comPolls open in Tunisian parliamentary election boycotted by oppositionDecember 17, 2022 | msn.comTop 10 customer hacks making workers’ lives miserableNovember 21, 2022 | msn.comSan Mateo: After 40 years, Windy City restaurant, Da Bears fan hangout closes todayAugust 20, 2022 | thestreet.com8 Stocks Under $10 Surging HigherMarch 28, 2024 | Vertical Research Advisory (Ad)“The Stock Market’s Bull Run is Far from Over” -BarronsBarron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!August 18, 2022 | msn.comNitish Kumar snubs BJP’s ‘jungle raj returns’ allegation, says will respond at an appropriate timeAugust 6, 2022 | msn.comMore afternoon downpours and storms SundayDecember 14, 2021 | usnews.comLogic's Hit '1-800-273-8255' May Have Saved American LivesSee More Headlines Receive NSPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (NSPH) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/16/2016Today3/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:NSPH CUSIPN/A CIK1105184 Webwww.nanosphere.us Phone+1-847-4009000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report NSPH Stock Analysis - Frequently Asked Questions How were (NSPH)'s earnings last quarter? (NSPH) (NASDAQ:NSPH) issued its quarterly earnings data on Monday, May, 16th. The medical research company reported ($0.55) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.59) by $0.04. The medical research company earned $6.60 million during the quarter, compared to the consensus estimate of $6.50 million. The firm's quarterly revenue was up 43.5% compared to the same quarter last year. During the same quarter last year, the business earned ($1.29) EPS. What other stocks do shareholders of (NSPH) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (NSPH) investors own include Cerus (CERS), Aeterna Zentaris (AEZS), Actinium Pharmaceuticals (ATNM), BIOLASE (BIOL), Molecular Templates (MTEM), Northwest Biotherapeutics (NWBO), Sarepta Therapeutics (SRPT), XOMA (XOMA), Cypress Semiconductor (CY) and Equity Bancshares (EQBK). This page (NASDAQ:NSPH) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (NSPH) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.